Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome.
COVID-19
COVID-19, coronavirus disease-2019
CRP, C-reactive protein
CT, computed tomography
IVIG, intravenous immunoglobulins
MIS, multisystem inflammatory syndrome
MIS-A, multisystem inflammatory syndrome in adults
MIS COVID-19
PIMS-TS, pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2
SARS-COV-2
SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2
TTE, transthoracic echocardiogram
coronary aneurysms
intravenous immunoglobulin
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
23
11
2020
revised:
20
01
2021
accepted:
21
01
2021
pubmed:
31
3
2021
medline:
31
3
2021
entrez:
30
3
2021
Statut:
ppublish
Résumé
A multisystem inflammatory syndrome mimicking Kawasaki disease has been increasingly reported, mainly in children, in the context of coronavirus disease-2019 (COVID-19). We report on the first case of coronary aneurysm resolution after treatment with steroids and intravenous immunoglobulins in an adult patient with multisystem inflammatory syndrome temporally associated with COVID-19. (
Identifiants
pubmed: 33782672
doi: 10.1016/j.jaccas.2021.01.012
pii: S2666-0849(21)00103-0
pmc: PMC7989672
doi:
Types de publication
Case Reports
Langues
eng
Pagination
581-585Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.